<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01593566</url>
  </required_header>
  <id_info>
    <org_study_id>Mahidol University</org_study_id>
    <nct_id>NCT01593566</nct_id>
  </id_info>
  <brief_title>Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction</brief_title>
  <acronym>FNB for ACLR</acronym>
  <official_title>Femoral Nerve Block Using 0.25% Versus 0.5% Bupivacaine for Analgesia After Arthroscopic Anterior Cruciate Ligament Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for
      analgesia after Anterior Cruciate Ligament (ACL) reconstruction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to first analgesic requirement</measure>
    <time_frame>48 hr</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain score scale</measure>
    <time_frame>48 hr</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Analgesia After ACL Reconstruction</condition>
  <arm_group>
    <arm_group_label>0.25% bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>femoral nerve block using 0.25% bupivacaine versus 0.5% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.5% bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>femoral nerve block using 0.25% bupivacaine versus 0.5% bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% Bupivacaine</intervention_name>
    <description>Femoral nerve block using 0.25% versus 0.5% bupivacaine</description>
    <arm_group_label>0.25% bupivacaine</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% Bupivacaine</intervention_name>
    <description>Femoral nerve block using 0.25% versus 0.5% bupivacaine for analgesia after ACL reconstruction</description>
    <arm_group_label>0.5% bupivacaine</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for ACL reconstruction

          -  ASA physical status I-II

          -  Body weight &gt; or = 50 kg.

        Exclusion Criteria:

          -  Patients with redo ACL reconstruction

          -  Contraindication to neuraxial block

          -  allergy to local anesthetics, sulfa, NSAIDs, morphine, paracetamol

          -  Patients with communication problem
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>arissara iamaroon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2012</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>arissara iamaroon</investigator_full_name>
    <investigator_title>associated professor</investigator_title>
  </responsible_party>
  <keyword>femoral nerve block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

